Home/Filings/4/0001181431-09-034345
4//SEC Filing

LOLLINI ROBERT J 4

Accession 0001181431-09-034345

CIK 0001459450other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:44 PM ET

Size

7.4 KB

Accession

0001181431-09-034345

Insider Transaction Report

Form 4
Period: 2009-07-01
LOLLINI ROBERT J
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2009-07-01+100,000100,000 total
    Exercise: $4.03Exp: 2019-07-01Common Stock (100,000 underlying)
  • Award

    Common Stock

    2009-07-01+21,00021,000 total
Footnotes (2)
  • [F1]Consists of a restricted stock unit award made pursuant to the Issuer's 2009 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest over a three-year period as to 1/3 of the units on each of June 15, 2010, June 15, 2011 and June 15, 2012.
  • [F2]The option vests over a four-year period as to 1/4 of the shares on each anniversary of the date of grant.

Issuer

Myriad Pharmaceuticals, Inc.

CIK 0001459450

Entity typeother

Related Parties

1
  • filerCIK 0001051710

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:44 PM ET
Size
7.4 KB